Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder (INR) HIV-1-infected patients treated with HAART

Authors
Publication date
10 June 2010
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      AIR Universita degli studi di Milano

      redirect
      oaioai:air.unimi.it:2434/145822
      Last time updated on 06/03/2019